Novo Nordisk
Novo Nordisk is a Danish multinational pharmaceutical company that specializes in diabetes care and hormone replacement therapies. Founded in 1923, the company is known for its innovative insulin products and GLP-1 receptor agonists, such as Ozempic, which are used for managing diabetes and aiding in weight loss. Novo Nordisk has a strong commitment to research and development, particularly in the fields of diabetes, obesity, and hemophilia.
Not in the pool (under ¢1).
Recent news mentions
Novo Nordisk is the company that manufactures Wegovy and applied for subsidies for specific patient groups.
Har samhället råd att låta bli att subventionera Wegovy?
Sweden· 2026-02-27
Novo Nordisk's spokespersons shake their heads at the argument for lifestyle changes.
Gad vide hvor meget sundhed vi kunne købe for prisen på Wegovy?
Denmark· 2026-02-17
Novo Nordisk is taking legal action against Hims and Hers for producing a copy of their weight loss drug Wegovy.
Novo Nordisk langer kraftigt ud efter konkurrentDenmark· 2026-02-05
Novo Nordisk fell 6.2 percent in New York after a significant drop in Copenhagen.
DN Direkt – Blandade bud när Wall Street famlade och föllSweden· 2026-02-05
Novo Nordisk fell 6.2 percent in New York after a significant drop in Copenhagen.
DN Direkt – Google-ägaren Alphabet slår förväntningarnaSweden· 2026-02-05The Trump administration recently negotiated a deal with Eli Lilly and Novo Nordisk to provide their weight loss drugs to Medicare at a discounted rate.
Medicare opens door to covering blockbuster drugs for weight loss
United States· 2025-12-24
Novo Nordisk is working on a similar experimental treatment recently acquired from China.
Un medicament revoluţionar împotriva obezităţii a înregistrat cele mai mari reduceri de greutate de până acum
Romania· 2025-12-12
Novo Nordisk was in competition with Pfizer to acquire Metsera but ultimately lost the bid.
Achat de la biotech Metsera : Pfizer sort gagnant face à Novo Nordisk, mais à quel prix
France· 2025-11-10
Novo Nordisk is competing with Pfizer and Metsera in the weight loss medication market.
Pfizer trækker Novo i retten i kamp om selskab med anderledes vægttabsmedicinDenmark· 2025-11-01
Novo Nordisk's bid for Metsera is the second major deal the company is pursuing in October.
Pfizer trækker Novo i retten i kamp om firma med anderledes vægttabsmedicinDenmark· 2025-10-31Novo Nordisk is facing significant changes in its board due to disagreements.
Novo Nordisks stærke mand taler nu om »en kæmpe fiasko«Denmark· 2025-10-21Novo Nordisk's stock is worth 39 percent less today than it was at the beginning of the year.
Amerikanske aktier sætter nye rekorderDenmark· 2025-10-03
Novo Nordisk's weight loss medication is among those recommended by the World Health Organization.
WHO vil anbefale vægttabsmedicin til behandling af fedmeDenmark· 2025-09-15
Novo Nordisk requested the inclusion of semaglutide in the public health system.
'apenas para quem consegue pagar'
Brazil· 2025-08-23
Novo Nordisk is a Danish insulin manufacturer that has faced challenges in meeting growth expectations.
Wann ist eine Bewertung zu hoch?
Switzerland· 2025-08-22
Novo Nordisk is being sued by numerous individuals for serious side effects caused by its popular weight loss drug Ozempic.
Ozempicu tootjalt nõutakse miljardeid eurosid valuraha
Estonia· 2025-08-19Novo Nordisk is a Danish pharmaceutical giant that has seen significant revenue despite a decline in stock price.
Analytiker kalder Novos fortsatte aktienedtur »meget paradoksal«Denmark· 2025-08-11Novo Nordisk is discussed regarding its stock performance and expectations for growth.
Novo-kollaps kostede milliarder i danskernes pensionsopsparingDenmark· 2025-08-10Novo Nordisk is a Danish pharmaceutical giant that has seen significant revenue growth despite a decline in stock price.
Analytiker kalder situationen »meget paradoksal«Denmark· 2025-08-06Novo Nordisk is a pharmaceutical giant that has presented impressive financial results over the years.
Aktierne bløder, men Novo har fortsat kurs mod flot regnskabDenmark· 2025-07-30Novo Nordisk experienced a historic drop in stock value.
Historisk dyk fik ung aktionær til at skynde sig at købe flere Novo-aktierDenmark· 2025-07-30Novo Nordisk is the Danish drugmaker that produces Ozempic and Wegovy.
Generic version of Ozempic, Wegovy to launch in Canada by Hims & Hers
Canada· 2025-07-10
Novo Nordisk is a major competitor in the obesity treatment market alongside Eli Lilly.
Novo Nordisk und Eli Lilly dominieren wohl noch JahreSwitzerland· 2025-06-25
Novo Nordisk is mobilized to obtain reimbursement for their obesity medications as soon as possible.
Vers un remboursement de nouveaux médicaments contre l'obésité: quel coût pour l'Assurance maladie?
Monaco· 2025-06-24Novo Nordisk has taken a new step towards maintaining its leading position in the market for treating severe obesity and diabetes.
Novo indgår milliardaftale om udvikling af ny medicinDenmark· 2025-05-14
Novo Nordisk alerted about counterfeit diabetes medication.
La FDA lanza alerta sobre distribución de medicamento para la diabetes y obesidad falso en la cadena de suministro de Estados Unidos | Servicio | Estados Unidos
Ecuador· 2025-04-19Novo Nordisk produces Ozempic and is also working on a pill for diabetes and obesity.
Eli Lilly corre a Wall Street grazie alla pillola anti-obesità e diabete in fase di studio (che sostituirà le iniezioni)
Italy· 2025-04-17
Novo Nordisk is the owner of the original Ozempic and has announced the arrival of Wegovy in Argentina.
Sale el "Ozempic nacional" inyectable en pleno plan oficial para bajar el precio de los medicamentos
Argentina· 2025-04-16
Novo Nordisk's stock decreased by 1.3 percent.
Taani ravimitootja löödi Euroopa väärtuslikuma ettevõtte kohalt minemaEstonia· 2025-03-25
The popular injection from Novo Nordisk is mentioned as a comparison for the new experimental pill from Eli Lilly.
Eli Lilly с ново хапче за отслабване; Китай настига САЩ в надпреварата за AI; Годишните продажби на BYD надхвърлиха 100 млрд. долара
Bulgaria· 2025-03-25